L-arginine, tetrahydrobiopterin, nitric oxide and diabetes

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 1, 2013, Pages 76-82

  Hoang, Hai H ^a   Padgham, Samuel V ^a   Meininger, Cynthia J ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

arginase; dihydrofolate reductase; endothelial dysfunction; endothelial nitric oxide synthase uncoupling; tetrahydrobiopterin

Indexed keywords

ARGINASE; ARGININE; CITRULLINE; DIHYDROBIOPTERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TETRAHYDROBIOPTERIN;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

ARGININE; BIOLOGICAL MARKERS; BIOPTERIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 84871926861     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835ad1ef     Document Type: Review

References (47)

1. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase bytetrahydrobiopterin in vascular disease. Arterioscl Thromb Vasc Biol 2004;24:413-420 (Pubitemid 38326132)
2. Crabtree MJ, Channon KM. Synthesis and recycling of tetrahydrobiopterin inendothelial function and vascular disease. Nitric Oxide 2011; 25:81-88
3. Morris SM. Recent advances in arginine metabolism: roles and regulation ofthe arginases. Br J Pharmacol 2009; 157:922-930
4. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascularendothelial dysfunction. Circulation 2002; 106:653-658 (Pubitemid 34851922)
5. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovasculardisease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-393 (Pubitemid 36159355)
6. Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induced coronary vasculardysfunction involves increased arginase activity. Circ Res 2008; 102:95-102
7. Tripolt NJ, Meinitzer A, Eder M, et al. Multifactorial risk factor intervention inpatients with type 2 diabetes improves arginine bioavailability ratios. DiabetMed 2012; 29:e365-e368. doi:10.1111/j.1464-5491.03743.x8.
8. Tang WH, Wang Z, Cho L, et al. Diminished global arginine bioavailability andincreased arginine catabolism as metabolic profile of increased cardiovascularrisk. J Am Coll Cardiol 2009; 2061-2067
9. Sourij H, Meinitzer A, Pilz S, et al. Arginine bioavailability ratios are associatedwith cardiovascular mortality in patients referred to coronary angiography.Atherosclerosis 2011; 218:220-225
10. Beleznai T, Feher A, Spielvogel D, et al. Arginase I contributes to diminishedcoronary arteriolar dilation in patients with diabetes. Am J Physiol Heart CircPhysiol 2011; 300:H777-H783
11. Romero MJ, Iddings JA, Platt DH, et al. Diabetes-induced vascular dysfunctioninvolves arginase I. Am J Physiol Heart Circ Physiol 2012; 302:H159-H166
12. Santhanam L, Christianson DW, Nyhan D, Berkowitz DE. Arginase andvascular aging. J Appl Physiol 2008; 105:1632-1642
13. Chandra S, Romero MJ, Shatanawi A, et al. Oxidative species increasearginase activity in endothelial cells through the RhoA/Rho kinase pathway.Br J Pharmacol 2012; 165:506-519
14. El-Hattab AW, Emrick LT, Craigen WJ, Scaglia F. Citrulline and arginine utilityin treating nitric oxide deficiency in mitochondrial disorders. Mol Genet Metab2012; doi: 10.1016/j.ymgme.06.018 [Epub ahead of print]
15. Haines RJ, Corbin KD, Pendleton LC, et al. Insulin transcriptionally regulatesargininosuccinate synthase to maintain vascular endothelial function. BiochemBiophy Res Commun 2012; 421:9-14
16. Mun GI, Kim I-S, Lee B-H, Boo YC. Endothelial argininosuccinate synthase 1regulates nitric oxide production and monocyte adhesion under static andlaminar shear stress conditions. J Biol Chem 2011; 286:2536-2542
17. Haines RJ, Corbin KD, Pendleton LC, Eichler DC. Protein kinase Ca phosphorylatesa novel argininosuccinate synthase site at serine 328 duringcalcium-dependent stimulation of endothelial nitric-oxide synthase in vascularendothelial cells. J Biol Chem 2012; 187:26168-26176
18. Erez A, Nagamani SCS, Shchelochkov OA, et al. Requirement of argininosuccinatefor systemic nitric oxide production. Nature Med 2011; 17:1619-1626
19. Jablecka A, Bogdanski P, Balcer N, et al. The effect of oral L-argininesupplementation on fasting glucose, HbA1c, nitric oxide and total antioxidantstatus in diabetic patients with atherosclerotic peripheral arterial disease oflower extremities. Eur Rev Med Pharmacol Sci 2012; 16:342-350
20. Piatti PM, Monti LD, Valsecchi G, et al. Long-term oral L-arginine administrationimproves peripheral and hepatic insulin sensitivity in type 2 diabeticpatients. Diabetes Care 2001; 24:875-880 (Pubitemid 33636062)
21. Lucotti P, Setola E, Monti LD, et al. Beneficial effects of a long-term oralL-arginine treatment added to a hypocaloric diet and exercise training inobese, insulin-resistant type 2 diabetic patients. Am J Physiol EndocrinolMetab 2006; 291:E906-E912
22. Monti LD, Setola E, Lucotti PCG, et al. Effect of a long-term oral L-argininesupplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2012; 14:893-900. doi: 10.1111/j.1463-1326.2012.01615.x
23. Wu G, Bazer FW, Davis TA, et al. Arginine metabolism and nutrition in growth,health and disease. Amino Acids 2009; 37:153-168
24. Dhar I, Dhar A, Wu L, Desai K. Arginine attenuates methylglyoxal-and highglucose-induced endothelial dysfunction and oxidative stress by an endothelialnitric oxide synthase-independent mechanism. J Pharmacol Exp Therapeut2012; 342:196-204
25. Wu G, Kelly KA, Hatakeyama K, et al. Regulation of endothelial tetrahydrobiopterinsynthesis by L-arginine. In: Thony B and Blau N, editors. Pterins,Folates, and Neurotransmitters in Molecular Medicine. SPS Verlagsgesellschaftmbh, Heilbronn, Germany; 2004. pp. 54-59
26. Kohli R, Meininger CJ, Haynes TE, et al. Dietary L-arginine supplementationenhances endothelial nitric oxide synthesis in streptozotocin-induced diabeticrats. J Nutr 2004; 134:600-608 (Pubitemid 38298503)
27. Heitzer T, Krohn K, Albers S, Meinertz T. Tetrahydrobiopterin improvesendothelium-dependent vasodilation by increasing nitric oxide activity inpatients with type II diabetes mellitus. Diabetologia 2000; 43:1435-1438
28. Settergren M, Bohm F, Malmstrom RE, et al. L-arginine and tetrahydrobiopterinprotects against ischemia/reperfusion-induced endothelial dysfunctionin patients with type 2 diabetes mellitus and coronary artery disease. Atherosclerosis2009; 204:73-78
29. Moens AL, Kietadisorn R, Lin JY, Kass D. Targeting endothelial and myocardialdysfunction with tetrahydrobiopterin. J Mol Cell Cardiol 2011; 51:559-563
30. Alkaitis MS, Crabtree MJ. Recoupling the cardiac nitric oxide synthases:tetrahydrobiopterin synthesis and recycling. Curr Heart Fail Rep 2012;9:200-210
31. Cunnington C, Van Assche T, Shirodarla C, et al. Systemic and vascularoxidation limits the efficacy of oral tetrahydrobiopterin treatment inpatients with coronary artery disease. Circulation 2012; 125:1356-1366
32. Noguchi K, Hamadate N, Matsuzaki T, et al. Increasing dihydrobiopterincauses dysfunction of endothelial nitric oxide synthase in rats in vivo. Am JPhysiol Heart Circ Physiol 2011; 301:H721-H729
33. Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct effects ofstatin treatment on arterial redox state and nitric oxide bioavailability in humanatherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxidesynthase coupling. Circulation 2011; 124:335-345
34. Youn JY, Gao L, Cai H. The p47phox-and NADPH oxidase organizer 1(NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediatesendothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunctionin a streptozotocin-induced murine model of diabetes. Diabetologia2012; 55:2069-2079
35. Crabtree MJ, Hale AB, Channon KM. Dihydrofolate reductase protectsendothelial nitric oxide synthesis from uncoupling in tetrahydrobiopterindeficiency. Free Rad Biol Med 2011; 50:1639-1646
36. Ohashi A, Sugawara Y, Mamada K, et al. Membrane transport of sepiapterinand dihydrobiopterin by equilibrative nucleoside transporters: a plausiblegateway for the salvage of tetrahydrobiopterin biosynthesis. Mol Genet Metab2011; 102:18-28
37. Ohashi A, Mamada K, Tsuboi I, et al. Asymmetric uptake of sepiapterin and7,8-dihydrobiopterin as a gateway of the salvage pathway of tetrahydrobiopterinbiosynthesis from the luminal surface of rat endothelial cells. Mol GenetMetab 2011; 104:404-406
38. Marinos RS, Zhang W, Wu G, et al. Tetrahydrobiopterin levels regulateendothelial cell proliferation. Am J Physiol Heart Circ Physiol 2001; 281:H482-H489
39. He T, Smith LA, Lu T, et al. Activation of peroxisome proliferator-activatedreceptor-d enhances regenerative capacity of human endothelial progenitorcells by stimulating biosynthesis of tetrahydrobiopterin. Hypertension 2011;58:287-294
40. Bowers MC, Hargrove LA, Kelly KA, et al. Tetrahydrobiopterin attenuatessuperoxide-induced reduction in nitric oxide. Front Biosci 2011; 3:1263-1272
41. Schmidt K, Neubauer A, Kolesnik B, et al. Tetrahydrobiopterin protectssoluble guanylate cyclase against oxidative inactivation. Molec Pharmacol2012; 82:420-427
42. Chen CA, Wang TY, Varadharaj S, et al. S-glutathionylation uncouples eNOSand regulates its cellular and vascular function. Nature 2010; 468:1115-1118
43. Zweier JL, Chen C-A, Druhan LF. S-glutathionylation reshapes our understandingof endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Anitoxid Redox Signal 2011;14:1769-1775
44. Druhan LJ, Forbes SP, Pope AJ, et al. Regulation of eNOS-derived superoxideby endogenous methylarginines. Biochemistry 2008; 47:7256-7263 (Pubitemid 351956374)
45. Chen C-A, Lin C-H, Druhan LJ, et al. Superoxide induces endothelial nitricoxide synthase protein thiyl radical formation, a novel mechanism regulatingeNOS function and coupling. J Biol Chem 2011; 286:29098-29107
46. Karuppiah K, Druhan LJ, Chen C-A, et al. Suppression of eNOS-derivedsuperoxide by caveolin-1: a biopterin-dependent mechanism. Am J PhysiolHeart Circ Physiol 2011; 301:H903-H911
47. Wu G, Haynes TE, Li H, Meininger CJ. Glutamine metabolism in endothelialcells: ornithine synthesis from glutamine via pyrroline-5-carboxylate synthase.Comp Biochem Physiol 2000; 126:115-123 (Pubitemid 30455911)